MALAT1 and metastatic malignant neoplasm in the lymph nodes: According to the study conducted by Zhang and colleagues, MALAT-1 expression was elevated in CRC patients, and it exhibited correlations with a poorer prognosis, lymph node metastases, and an advanced TNM stage.